Alcon Shareholders Approve Dividend, Elect Directors
HUENENBERG, Switzerland – May 20, 2010 – Alcon, Inc. (NYSE:ACL) announced the following actions
were taken by shareholders at the company’s Annual General Meeting of Shareholders held today in Zug,
The company also announced that its board of directors re-elected Cary Rayment as its non-executive
chairman and re-elected Francisco Castañer as its vice-chairman in a board meeting that followed the completion
of the Annual General Meeting of Shareholders.
Alcon, Inc. is the world’s leading eye care company, with sales of approximately $6.5 billion in 2009. Alcon,
which has been dedicated to the ophthalmic industry for 65 years, researches, develops, manufactures and
markets pharmaceuticals, surgical equipment and devices, contacts lens solutions and other vision care products
that treat diseases, disorders and other conditions of the eye. Alcon operates in 75 countries and sells products
in 180 markets. For more information on Alcon, Inc., visit the Company’s web site at www.alcon.com .
# # #
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements principally relate to statements
regarding the expectations of our management with respect to the future performance of various aspects
of our business. These statements involve known and unknown risks, uncertainties and other factors
which may cause our actual results, performance or achievements to be materially different from any
future results, performances or achievements expressed or implied by our forward -looking statements.
Words such as "may," "will," "should," "could," "would," "expect," "plan," "anticipate," "believe,"
"hope," "intend," "estimate," "project," "predict," "potential" and similar expressions are intended to
identify forward-looking stat